Dan
Analyst
Cantor Fitzgerald
Equibles does not estimate personal net worth.
About Dan
Dan is recorded as Analyst at Cantor Fitzgerald. Dan has spoken on 1 earnings call across 1 company, most recently for Arcus Biosciences, Inc. on May 6, 2025. The companies whose calls Dan spoke on are classified in the Healthcare sector.
Dan on recent calls
“I was wondering if you could kind of set expectations for your combination with VolRU and what you're looking for in the IO-NAE setting and for a potential pivotal frontline trial, what would you be comparing your doublets to?”
Affiliation history
-
Cantor Fitzgerald
Analyst
Transcript header (unverified)
Current